Rogers Becomes Aceto’s President
Executive Summary
Steven Rogers has become president of ailing US firm Aceto, in the wake of William Kennally’s termination as president and CEO. Meanwhile, the firm’s chief financial officer has also stepped down.
You may also be interested in...
Aceto 'No Longer Requires' CEO Kennally
Aceto has terminated William Kennally’s tenure as president and CEO of the struggling US firm, following deals struck to divest its Rising Pharmaceuticals generics business and chemicals unit as part of bankruptcy proceedings. Meanwhile, the Nasdaq listing has confirmed that Aceto will be delisted in mid-June.
Aceto Strikes Deal To Offload Rising For Just US$15m
Aceto has struck a deal to sell its Rising Pharmaceuticals unit and related businesses to Shore Suven Pharma for US$15 million. The agreement comes shortly after Aceto agreed to divest its chemicals business assets for US$338 million after filing Chapter 11 bankruptcy petitions in the US.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.